NAXE and glaucoma: Because reduced AIBP expression in the retina is linked to glaucomatous neuroinflammation and mitochondrial dysfunction [12], sustained expression of AIBP, which promotes selective removal of excess cholesterol from TLR4-occupied lipid rafts in inflammatory retinal cells, could become a potential treatment to reduce neuroinflammation and mitochondrial dysfunction in human glaucoma.